FeaturesSignalPricingFounders
Log inGet started free
LV

Lilly Ventures

Corporate VCActive

Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector.

Indianapolis, United StatesFounded 2014lilly.com/partners
63
Investments
23
Exits
—
AUM
36.5%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lilly Ventures.

Get started free

Investment Thesis & Strategy

Lilly Ventures invests in life sciences companies across various stages, leveraging its expertise in the sector to support innovation and growth.

Investment Activity

Deals per year over the last 7 years

1
2016
2
2017
2
2018
0
2019
0
2020
5
2021
2
2022

Portfolio Companies

Selected investments from their portfolio of 63 companies

L
Lycia Therapeutics
Biotech · Series B, 2022
Active
R
Rgenta Therapeutics
Biotech · Series A, 2022
Active
O
Obsidian Therapeutics
Biotech · Series B, 2021
Active
V
Vera Therapeutics
Biotech · Series B, 2021
Active
R
RemeGen
Biotech · Growth, 2021
Active
T
Triumvira Immunologics
Biotech · Series A, 2021
Active
X
Xilio Therapeutics
Biotech · Series B, 2021
Active
C
Cabaletta Bio
Biotech · Series A, 2018
Active
R
Rgenix
Biotech · Series A, 2018
Active
N
NextCure
Biotech · Series B, 2017
Active
S
Surface Oncology
Biotech · Series B, 2017
Active
R
Rani Therapeutics
Biotech · Series B, 2016
Active

Frequently Asked Questions

Lilly Ventures focuses on Series A, Series B stage investments.

Related Investors

Lumina Impact Ventures

Indianapolis, United States · 4 deals

Brand Capital

Mumbai, India · 570 deals

Salesforce Ventures

San Francisco, United States · 463 deals

Qualcomm Ventures

San Diego, United States · 374 deals

SoftBank Capital

Tokyo, Japan · 279 deals

Samsung Ventures

Seoul, South Korea · 231 deals